CatherineC(Choy)SmithMD
Oncology • San Francisco, CAHematologic Oncology
Assistant Professor, Medicine, UCSF School of Medicine
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 415-353-2467
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2006 - 2009
Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
Duke University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2005 - 2025
MA State Medical License 2005 - 2006- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen Start of enrollment: 2009 Nov 01
- Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) Start of enrollment: 2011 Nov 21
Publications & Presentations
PubMed
- 125 citationsCharacterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 “Gatekeeper” F691L Mutation with PLX3397Catherine C. Smith, Chao Zhang, Kimberly C. Lin, Elisabeth A. Lasater, Ying Zhang
Cancer Discovery. 2015-04-06 - 162 citationsReactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV...Amy Flaxman, N G Marchevsky, D Jenkin, J Aboagye, Parvinder K. Aley
Lancet. 2021-09-11 - 980 citationsSafety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, ph...M N Ramasamy, Angela M. Minassian, Katie J. Ewer, Amy Flaxman, P M Folegatti
Lancet. 2020-12-19
Abstracts/Posters
- Combined Single-Cell DNA Genotyping and Protein Quantification (DAb-seq) in Acute Myeloid Leukemias Reveals Distinct Immunophenotypic Subsets Among Pathogenic ClonesCatherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Single Cell Sequencing Reveals Evolution of Tumor Heterogeneity of Acute Myeloid Leukemia on QuizartinibCatherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative NeoplasmsCatherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Astellas Presents New Data on XOSPATA® (Gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual MeetingDecember 2nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
